Validation of a rapid and sensitive high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds
Authors:
- Laura ElseLELaura Else
- Victoria WatsonVWVictoria Watson
- John TjiaJTJohn Tjia
- Andrew HughesAHAndrew Hughes
- Marco SiccardiMSMarco Siccardi
- Saye KhooSKSaye Khoo
- David BackDBDavid Back
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 878 (19) , 1455-1465
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008HIV Medicine, 2008
- A pharmacokinetic study of etravirine (TMC125) co‐administered with ranitidine and omeprazole in HIV–negative volunteersBritish Journal of Clinical Pharmacology, 2008
- The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteersBritish Journal of Clinical Pharmacology, 2008
- A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV‐positive subjectsBritish Journal of Clinical Pharmacology, 2008
- Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteersBritish Journal of Clinical Pharmacology, 2008
- Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteersBritish Journal of Clinical Pharmacology, 2008
- FosamprenavirClinical Pharmacokinetics, 2006
- Low Nevirapine Plasma Concentrations Predict Virological Failure in an Unselected HIV-1-Infected PopulationClinical Pharmacokinetics, 2003
- Drug Interactions Between Antiretroviral Drugs and Comedicated AgentsClinical Pharmacokinetics, 2003
- Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase InhibitorsClinical Pharmacokinetics, 2001